Tapered Warfarin or Interrupted Warfarin With Heparin Bridging for Pacemaker or Defibrillator Implantation "PACEBRIDGE"


Phase 3 Results N/A

Summary of Purpose

Approximately 2 million patients in North America are currently treated with the blood thinner warfarin. These patients have every year more than 200,000 invasive procedures, for which warfarin must be stopped to avoid bleeding complication. To protect the patient against blood clots and stroke while warfarin is stopped,... Trial Stopped: Change of practice made further recruitment impossible

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 1 April 2016.

1 Dec 2007 19 Mar 2014 1 Nov 2013 1 Mar 2014 1 Apr 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Single Blind (Outcomes Assessor)
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Parallel Assignment


Not available